Statement Of Financial Position [Abstract]

BerGenBio - Filing #5877180

Concept	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Non-current assets	—	—	—	1,254,000 NOK	—	—	—	—	—	431,000 NOK	—	—	—	—	—
Current assets [abstract]
Cash and cash equivalents	—	—	—	140,155,000 NOK	—	—	—	—	—	156,421,000 NOK	150,803,000 NOK	—	—	—	—
Current assets	—	—	—	154,543,000 NOK	—	—	—	—	—	173,904,000 NOK	—	—	—	—	—
Assets	—	—	—	155,796,000 NOK	—	—	—	—	—	174,335,000 NOK	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	39,087,000 NOK	—	—	—	—	—	268,869,000 NOK	—	—	—	—	—
Retained earnings	—	—	—	22,019,000 NOK	—	—	—	—	—	189,234,000 NOK	—	—	—	—	—
Share premium	—	—	—	8,899,000 NOK	—	—	—	—	—	854,000 NOK	—	—	—	—	—
Equity	22,019,000 NOK	52,696,000 NOK	8,899,000 NOK	122,702,000 NOK	39,087,000 NOK	854,000 NOK	268,869,000 NOK	46,987,000 NOK	189,234,000 NOK	127,476,000 NOK	88,498,000 NOK	8,866,000 NOK	35,780,000 NOK	0 NOK	43,852,000 NOK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities	—	—	—	818,000 NOK	—	—	—	—	—	0 NOK	—	—	—	—	—
Current liabilities [abstract]
Current provisions [abstract]
Current provisions	—	—	—	0 NOK	—	—	—	—	—	42,000 NOK	—	—	—	—	—
Current liabilities	—	—	—	32,277,000 NOK	—	—	—	—	—	46,859,000 NOK	—	—	—	—	—
Liabilities	—	—	—	33,095,000 NOK	—	—	—	—	—	46,859,000 NOK	—	—	—	—	—
Equity and liabilities	—	—	—	155,796,000 NOK	—	—	—	—	—	174,335,000 NOK	—	—	—	—	—